HemaCare

HemaCare, a Charles River company, is a global leader in the supply and customization of human-derived biological products and services for biomedical research, drug discovery, and process development. Founded in 1978, HemaCare has spent over four decades building an extensive donor network and establishing itself as a trusted partner for pharmaceutical companies, biotechnology firms, and research organizations worldwide.

The company operates FDA-registered, AABB-certified, and state-licensed donor centers across the United States, including locations in Northridge, CA, Bothell, WA, Memphis, TN, and Lowell, MA. HemaCare's comprehensive offerings include the collection and customization of various blood products such as whole blood, bone marrow, white blood cells (apheresis), and mobilized white blood cells. These cellular materials support critical applications in scientific research, drug development, and cell therapy manufacturing globally.

In 2020, HemaCare was acquired by Charles River Laboratories for $380 million, further strengthening its position in the cell therapy and biologics space. The company continues to play a vital role in advancing medical breakthroughs by providing highly characterized and diverse donor-derived cells that serve as essential raw materials for cutting-edge research and therapeutic development.